Managing hyperkalemia in cardiorenal patients: novel therapeutic insights to optimize outcomes

10' education - Aug. 28, 2019 - Prof. Matthew Weir, MD - Baltimore, MD, USA - Online CME

Prof. Weir addresses the need for management of hyperkalemia in CKD patients, discusses RAASi enabling and presents novel therapeutic considerations.

Educational information

This lecture by prof. Matthew Weir was part of an accredited symposium "RAASi and Hyperkalemia in Cardiorenal Disease: Opportunities for optimizing outcomes" held during ERA-EDTA 2019 in Budapest, Hungary.

Faculty

Matthew R. Weir, M.D. is attending physician and Director of the Division of Nephrology in the Department of Medicine at the University of Maryland Hospital, Baltimore. He is also Professor of Medicine at the University of Maryland School of Medicine.

Disclosures

This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.

Funding

Funding for this educational program was provided by an unrestricted educational grant from Vifor Fresenius Medical Care Renal Pharma.

View slides of the presentation by prof. Weir

Online-CME

This is available as accredited online CME for members. Click the button below to enroll:

Enroll

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.